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Diffusion weighted MRI.Abstract Objective: Non-invasive preoperative detection of axillary nodal metastasis is beneficial
for the outcome of breast cancer patients. We aimed to determine the value of DWMRI, ADC and
their combination with MRI morphological criteria in detecting axillary metastasis.
Methods: We included recently diagnosed forty breast cancer patients. MRI morphological
criteria, signal intensity on DWI, and ADC value were assessed and compared between metastatic
and non-metastatic LNs using histopathological findings as reference standard. Sensitivity,
specificity, PPV, NPV and accuracy for each variable and cutoff value of ADC were evaluated.
Results: No statistically significant difference between metastatic and non-metastatic LNs in short
axis diameter or L/S ratio (p value: 0.87 and 0.82 respectively); however, loss of fatty hilum, high
signal intensity on DWI and low ADC value were significant with increasing sensitivity on their
combination. The mean ADC was 0.96 ± 0.9  103 mm2/s for metastatic and 1.53e value;
WI, low
SPAIR,
ho-echo
C curve;
ail.com
660 F. Zaiton et al.± 0.6  103 mm2/s for benign LNs with cutoff value 1.09  103 mm2/s and sensitivity (94.5%),
specificity (93.6%), PPV (96%), NPV (94.7%) and accuracy (95.6%).
Conclusion: DW-MRI and ADC per se or in combination with loss of the fatty hila is a promising
and supportive tool for detection of axillary LNs metastasis.
 2016 The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by Elsevier B.V.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).1. Introduction
Determining the axillary lymph node status is a crucial factor
in treatment planning and prognosis determination in patients
with breast cancer (1). Therefore, it is very important to preop-
eratively detect the lymph node metastasis. However, the
accuracy of preoperative diagnosis of nodal metastasis is still
challenging (2,3).
Traditionally, axillary dissection is used to obtain prognos-
tic information in breast cancer; however, it is an invasive
procedure that may adversely affect the quality of life (2,4).
Different imaging techniques such as magnetic resonance
imaging, computed tomography and ultrasonography as well
as and physical examination have not proven to be accurate
in the detection of nodal metastasis (5–11).
Up to date used by conventional imaging modalities are
shape, size, extracapsular spread and abnormal inner struc-
tures. The size is the most used parameter for the diagnosis,
whereas the presence of central necrosis is the most accurate
sign of malignity (12). Nevertheless several studies showed that
these criteria are not enough to differentiate benign from
malignant lymph nodes (13,14).
All these criteria remain questionable, and guidelines for
the discrimination between non-metastatic and metastatic
lymph nodes vary widely (6–8,15–17).
Diffusion-weighted MR imaging (DWI) analyzes water
motion in tissues and any movements of the water protons
leads to alteration of the signal intensity in DWI and ADC
maps (12).
The purpose of our study was to assess the value of adding
the DW-MRI including ADC measurement to the morpholog-
ical criteria on increasing the detectability of metastatic lymph
nodes in cancer breast patients.
2. Patients and methods
2.1. Study design and population
This study was prospectively conducted during the period
from July 2013 to July 2015 at Diagnostic Radiology, Surgery
and pathology departments, and included 52 breast cancer
female patients referred to our institute for preoperative
MRI evaluation. The study was approved by the local ethical
committee, all patients were informed of the study aims and an
informed written consent was obtained before participation.
We included recently diagnosed breast cancer patients
defined as TNM stage I and II (18).
The Exclusion criteria were as follows: patients with
carcinoma in situ (ductal or lobular; DCIS or LCIS) as they
do not generally undergo axillary clearance surgery, previoussurgical exploration of the axilla, biopsy or radiation therapy
to axillary LNs.
From 52 included patients only 40 patients completed the
study and the other 12 patients were further excluded due to
patients unfit for surgery (3 patients), bad general condition
interfere with completeness of MRI examination (4 patients),
bad quality image from motion artifact (3 patients), and LN
outside field of diffusion (2 patients). Patients’ age ranged
between 29 and 65 years with mean age of 32 ± 7 and the
affected side was left in 16 patients, right in 22 patients and
bilateral affection in 2 cases.
All patients were subjected to MRI examination of the
breast and axilla including all LNs levels (levels I, II and
III), followed by axillary lymph node biopsy or surgical
axillary clearance within two weeks of MRI examination
(range from 2 to 15 days) by breast conservative surgery and
axillary clearance.2.2. MRI examination
Breast and axillary MRI examination was performed using a
1.5-T superconductive magnet (Intera Achiva Nova Dual
system, Philips Healthcare, Best, the Netherlands). All patients
were scanned with breast coil in the standard prone position.
MR evaluation consisted of DWI and dynamic contrast
enhanced MRI (DCE-MRI). The MR protocol is as follows:
 Initially coronal spectral selective attenuation inversion
recovery (SPAIR) T2 weighted bilateral images of the entire
breast were obtained with the following parameters: repeti-
tion time/echo time: 6000/140 ms, NEX: 2, matrix:
320  190 pixels, slice thickness: 5/1 mm.
 Then conventional breast MRI is performed:
– Axial T1 weighted with fast spin echo sequence: repeti-
tion time/echo time: 467/9.9 ms, slice thickness 4/0 mm,
matrix: 320  224, NEX: 1.
– Axial T2 weighted short time inversion recovery (STIR):
repetition/echo time: 6000/140 ms, slice thickness 4/0 mm,
matrix: 320  190, NEX: 2.
– Sagittal T1 weighted fast spin echo images: repetition
time/echo time: 617/15.5 ms, slice thickness 4/0 mm,
matrix: 320  224, NEX: 1.
 Dynamic MR images were sequentially performed before 0,
90, 180 and 270 s after injection of 0.1–0.2 mmol/kg body
weight of Gadopentatedimeglumine. Axial fat suppressed
T1 weighted (3D gradient echo) images were obtained with
the following parameters: TR/TE: 5.8/2.8 ms, FOV:
35  35 cm, matrix: 320  320, slice thickness: 1.5 mm,
NEX: 1.
Table 1 2  2 Contingency table between the detectability of
a high-signal-intensity node on DWI and node metastasis.
SI Malignant Benign Total
High 122 12 134
Low 4 70 74
Total 126 82 208
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spin echo-echo planer imaging (SE-EPI) sequence in axial
plane with spectral spatial fat suppression and parallel imag-
ing (reduction factor = 2) were done. Sensitizing diffusion
gradients were done with b0 & b1000 s/mm2 with the follow-
ing parameters: repetition time (TR): 4600–6800 ms, echo
time (TE): 51 ms, field of view (FOV): 360x360 mm, flip angle:
90, Number of excitation (NEX): 2, matrix: 120x88 pixels,
slice thickness: 4 mm and slice gap: 0 mm.
2.3. Image analysis
All MR images were reviewed by two radiologists (prestudy
radiological investigation was not included in the evaluation)
on separate sessions. All LNs detected on MRI examination
were examined at SPAIR T2WI as an anatomical reference,
and CE-FS-T1WI was used to rule out any misidentification
of blood vessels as lymph nodes and lastly at DWI. The ADC
values were calculated for all examined axillary lymph nodes.
To ensure accurate ADC values of the suspected lymph nodes,Fig. 1 A 46 year old female patient: (a and b) axial CE-FS-T1WI d
axillary LNs displaying oval shape and obliterated fatty hilum. (c and d
ADC value measures 0.644  103 mm2/s denoting restricted diffusionthe ROI is placed on the maximum diameter covering nearly
the whole LN, the area of the ROI in the selected LN ranged
between 20 and 60 mm2 with a mean of 35 mm2.
Each lymph node was identified and numbered on the MR
images and printed on film. Criteria to differentiate benign
from malignant lymph nodes included size, the long to short
axis (L/S) ratio, lost fatty hilum, and signal intensity on
DWI and ADC values. A short-axis diameter >10 mm, a ratio
of long to short axis diameter <1.5 and diffusion restriction
were considered indicative of a metastasis (16).
The detected lymph nodes were classified according to the
anatomical location levels: Level I lateral to the pectoralis
minor muscle (lower axillary nodes); level II located beneath
the pectoralis minor muscle (midaxillary nodes) and level III
medial to the pectoralis minor muscle (apical axillary nodes)
(16). All axillary LNs detected by MRI examination were
subjected to biopsy or surgical resection, surgeon doing the
operation attended the image analysis session to ensure that
all LNs seen on DWI were subjected to surgical resection
and a diagram of the selected lymph nodes was simulated
and made available to the surgeon in the operating room.
Biopsy of the selected LNs was done by a radiologist under
ultrasound guidance in 25 cases.
2.4. Surgical evaluation
Axillary lymph node dissection was done for 15 cases. This
dissection was started by removal of all areolar tissues in front
of the axillary vein starting beneath the tendinous portion of
the pectoralis minor muscle after its division and dissectionemonstrates malignant RT breast mass and multiple enlarged RT
) DWI & color coded ADC map showing high SI & blue color, and
(histopathologically proved as metastatic).
Fig. 2 A 52 year old female patient: (a) axial T2W TSE demonstrates malignant RT breast mass and (b) axial T2W (SPAIR) shows two
enlarged RT axillary LNs displaying round shape and attenuated fatty hilum. (c and d) DWI & color coded ADC map showing focal
hyperintensity (arrow) on DWI that displays green color on ADC map, measuring 0.768  103 mm2/s at ADC value denoting focal
restricted diffusion of focal malignant infiltration.
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node is removed.2.5. Histopathological correlation
All samples were evaluated for evidence of cancer by a pathol-
ogist who was blinded to the MRI results. The excised lymph
node was analyzed by serial sectioning of the whole node after
formalin fixation and paraffin embedding. Every section of
200 mm was stained with hematoxylin eosin and by immuno-
histochemistry (IHC) using a monoclonal antibody to cytokeratin
(KL1 Immunotech, France) for the detection of micrometastasis
(<2 mm) and isolated tumor cells (0.2 mm).
Final diagnosis for all lymph nodes was made by correlation
between magnetic resonance diffusion readings and histopatho-
logical sections which were performed in all cases.2.6. Statistical analysis
Data obtained by MRI, surgery and histopathology were col-
lected and compared. Statistical analyses were performed by
using SPSS, Version 15.0.1, Inc. (Chicago, IL), 80% power
of the study and 95% CI and level of significance 0.05.The mean size, L/S ratio and the mean ADC values were
compared among benign and metastatic axillary lymph nodes
using Chi-square test, t test and Mann–Whitney U test. Sen-
sitivity, specificity, accuracy, positive and negative predictive
values of data obtained by MRI examination in differentiat-
ing axillary LNs were analyzed using the histopathological
findings as the gold standard. The cutoff value of ADC to
differentiate between benign and metastatic axillary lymph
nodes was calculated using receiver-operating characteristic
curve analysis.
When there is difference in numbers of lymph nodes
counted on MR images and those were resected during sur-
gery, nodes seen in MRI only were included in the statistical
analysis.3. Results
Among 464 surgically excised LNs, 208 LNs were coordinated
radiologically and pathologically and included in the analysis
(126 (60.5%) metastatic and 82 (39.5%) benign). All of those
208 lymph nodes were detected in all series of MRI examina-
tion with a median of 6 LNs/patient (ranged from 2 to 10).
DW MRI revealed high signal intensity in 134 LNs (64.4%)
and low signal in 74 (35.6%). There are 12 false positive
Fig. 3 A 47 year old female patient: (a) axial DWI demonstrates malignant RT breast mass with restricted diffusion and (b) coronal
T2W (SPAIR) shows multiple variable sized RT axillary LNs with preserved fatty hila. (c and d) Axial DWI & color coded ADC map: two
lymph nodes display low signal intensity on DWI and red color on ADC map. The ADC value was calculated to be 1.4  103mm2/s
denoting free diffusion (histopathologically proved as being metastatic).
Value of MRI for predicting axillary metastasis 663LNs (proved to be inflammatory at histopathology) and
another four false negative LNs were seen of low signal at
DWI MRI (3 staged as N0(i+) and one as N1mi at
histopathology) (Figs. 3 and 4).
The 2  2 contingency table (Table 1) provided a sensitivity
of 96%, a specificity of 85%, a PPV of 91%, an NPV of 94%,
and an accuracy of 92%, with P= 0.001 when the detectabil-
ity of metastatic lymph nodes using diffusion restriction as a
criterion compared with histopathological examination.
The median of short axis diameter of the metastatic and
non- metastatic lymph nodes was 9.5 and 7.5 with a range of
4.2–28.9 mm and 3.5–28.4 mm respectively, and the mean of
the long/short axis ratio was lower for metastatic LN measur-
ing 1.3 ± 0.46 (0.8–2.09) than the non-metastatic one measur-
ing 1.6 ± 0.5 (1.05–2.9). No statistically significant difference
detected between the metastatic and non-metastatic LNs
regarding these two variables with p= 0.87 for short axis
diameter and 0.82 for L/S ratio.
The preservation or absence of fatty hilum in metastatic
and non-metastatic LNs was found statistically significant
(P= 0.001). It was preserved in 52 (63.4%) non-metastatic
LNs and 48 (38%) metastatic LNs and lost in 30 (36.6%)
non-metastatic and 78 (62%) metastatic LNs, with 61.9% sen-
sitivity, 63.4% specificity, 72.2% PPV, 52% NPV and 62.5%
accuracy.
The mean ADC value was significantly lower for malig-
nant than for benign LNs measuring 0.86 ± 0.9  103
mm2/s (ranged of 0.13–2.28) and 1.53 ± 0.6  103 mm2/s(range of 0.94–2.89) respectively (P value = 0.01) (Figs. 1
and 2).
The AUC was 0.924 (95% confidence interval, 0.888–
0.959). Using an ADC value of 1.09  103 mm2/s as a cutoff
value for distinguishing metastatic from non-metastatic LNs
had sensitivity of 94.5%, a specificity of 93.6%, PPV of
96%, NPV of 94.7% and accuracy of 95.6% (Fig. 5).
The degree of agreement between ADC value and high sig-
nal intensity of lymph nodes at DW MRI was highly signifi-
cant (k1 = 0.96 and P= 0.01).
Combination of the included predictors has improved the
detection of lymph node metastasis, as adding the presence
of high signal intensity on DW MRI to the measured ADC
values increased the sensitivity, specificity, PPV, NPV and
accuracy, and this was also yielded when adding the lost fatty
hila to the high signal of the LNs on DW MRI alone, with
more increase achieved when using these three variables in
association; on the other hand, no changes in the results were
noted when we used the size criteria in addition, as shown in
Table 2.
The N staging of the 126 metastatic LNs was N1mi = 4,
N1 = 110 and N2 = 12 LNs. There was negative correlation
between the value of ADC and the histopathological N stage
of the lymph nodes, which is statistically significant
(p= 0.001). Also the sensitivity, specificity, PPV, NPV and
accuracy of measuring ADC value in the diagnosis of meta-
static LNs were increased with increased nodal staging
(Table 3).
Fig. 4 A 33 year old female: (a) axial CE-FS-T1WI demonstrates malignant RT breast mass and (b) T1W fat suppression shows multiple
bilateral axillary LNs of variable shape and size and attenuated fatty hila. (c and d) Axial DWI & color coded ADC map: the largest three
lymph nodes (*) display high SI on DWI, blue color on ADC map with ADC value ranging from 0.987 to 1.17  103 mm2/s denoting
restricted diffusion (diagnosed radiological as being metastatic). The other LNs display low SI on DWI, green color on ADC map and
ADC value measures ranging from 1.7 to 1.8  103mm2/s denoting free diffusion (diagnosed radiological as non-metastatic). However,
all described LNs were negative for malignancy at histopathology.
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(n= 126) revealed the following: N1mi = 4, N1 = 110 and
N2 = 12 LNs. There was negative correlation between the
value of ADC and the degree of the nodal involvement, which
is statistically significant (p= 0.001). Also the sensitivity,
specificity, PPV, NPV and accuracy of measuring ADC value
in the diagnosis of metastatic LNs were increased with
increased nodal affection (Table 3).4. Discussion
Worldwide, breast cancer is the commonest form of cancer in
women (19,20).
Axillary lymph node metastasis is one of the main factors
affecting the prognosis of patients with breast cancer, and
the 5-year survival for breast cancer patients has been changed
according to the nodal affection; for example, in node-negative
disease it measures 82.8% compared with 73% in 1–3 positive
nodes, 45.7% in 4–12 positive nodes, and 28.4% in cases with
more than 13 positive nodes (10,21,22).
However, diagnosis of these nodes currently requires patho-
logic analysis of the tissue biopsy or dissection after surgerywhich considered the gold standard for diagnosis; unfortu-
nately both of them are invasive procedures (23).
The investigators made extensive effort to develop a nonin-
vasive technique that accurately preoperatively assesses both
sentinel and distant axillary lymph nodes metastasis, aiming
to reduce the time and the cost of diagnosis as well as the risk
of complication to the patients due to unnecessary axillary
sampling (24).
Traditionally the size based criteria have been used as indi-
cators for metastasis considering a lymph node with short axis
more than 10 mm is positive for malignancy (13,25); however,
many authors had studied the relation between the lymph node
size and metastasis, they concluded that no significant relation
observed between the short axis diameter and metastasis
(15,16,24,26–30), and they mentioned a low sensitivity ranged
from 53% to 62%, also in the study of Obwegeser et al. (31).
On 1276 axillary lymph nodes they found that 13.7% of lymph
nodes with metastasis had short axis ranged from 5 to 9 mm, in
agreement with those studies where we found no statistically
significant difference in the short axis diameter or the L/S ratio
between metastatic and benign nodes and we found an overlap
in the diameter of the short axis and the L/S ratio between
both groups (p value: 0.87 and 0.82 respectively).
Fig. 5 Receiver operating characteristic curves for ADC value
for differentiation between metastatic and benign axillary lymph
nodes.
Value of MRI for predicting axillary metastasis 665In studies of Gupta et al. (32), and Ragheb et al. (33), they
reported that S/L ratio was an effective indicator for
metastatic nodes. This discrepancy may be explained by the
inclusion of different anatomical and histological subtypes as
in both studies they examined head and neck lymph nodes.
Small number of studies had examined the relation
between loss of the fatty hilum in axillary LNs and metasta-
sis. Mortellaro et al. (34), in their study concluded that there
was a significant correlation between the loss of the fatty
hilum of the axillary lymph nodes (on T2 STIR images)
and positive metastatic nodes and they declared that this
study was the first report of this relation. Also in the study
of Kaur et al. (35), they examined the axillary lymph nodes
using ultrasound and they described a sensitivity, specificity,
PPV, NPV and accuracy of 70.45%, 83.3%, 91.61%,
53.5% and 74.69% respectively for the loss of the fatty hila
as a predictor for axillary nodal metastasis, and in our study
we found that the relation between the loss of the fatty hilum
and the metastatic involvement of the LNs was statistically
significant, giving 61.9% sensitivity, 63.4% specificity,
72.2% PPV, 52% NPV and 62.5% accuracy which were less
than those described by Kaur et al. (35), and this difference
may be due to the usage of different imaging modalities in
the two studies.Table 2 The sensitivity, specificity, PPV, NPV and accuracy of var
Variables Sensit
High SI DW MRI 96.8
High signal with ADC value 98.4
Fatty hilum absence 55.6
Fatty hilum absence with High SI at DW-MRI 97
Fatty hilum absence with High SI at DW-MRI and ADC value 98.4Diffusion-weighted technique is a functional magnetic reso-
nance imaging that does not require contrast administration; it
has been intensively investigated in both preclinical models
and patients with cancer for lymph node assessment (36).
The potentiality in the identification of nodes on DWI was
significantly higher than that on T2WI, and the axillary lymph
nodes were shown with marked high signal intensity when
compared with the adjacent muscle and surrounding normal
vessels on DWI that made it easy to identify (37).
In the present study, high signal intensity of the axillary
LNs on DWI was detected in 134 nodes (122 with and 12 with-
out metastasis) while low signal intensity was detected in 74
LNs (4 with and 70 without metastasis), the presence of high
signal on DWI in metastatic LNs was found to be statistically
significant (P value = 0.001), and this was in agreement with
Perrone et al. (12) and Ismail et al. (38).
However, Wang et al. (24) in their study on rabbit models,
found that both the metastatic and the inflammatory lymph
nodes presented with high SI on DWI and that there was no
statistical significant difference comparing the signal intensity
on DWI between inflammatory and metastatic LNs; they con-
cluded that visual assessment of DWI to differentiate meta-
static from inflammatory axillary lymph nodes was difficult
because both groups showed high signal intensities on DWI.
Measuring the ADC value yielded quantitative assessment
of the water diffusivity in the tissue and (39) the larger the
b-value is, the greater the degree of signal attenuation from
the motion of water molecules is (39,40). In the study of Wang
et al. (24), they use a high b-value of 800 s/mm2, and they
assumed that high b value could evaluate water diffusion more
exactly and eliminate the effects of capillary perfusion.
Also in our study, DWI was carried out at high b value of
1000 s/mm2 and the obtained ADC values were significantly
lower for LNs with metastasis than those without metastasis,
but there was an overlap between both groups. Many other
previous studies had published the same results (12,24,38,41);
Wang et al. (24) gave an explanation for this overlap as they
found that not all malignant LNs were totally replaced by
tumor cells, resulting in areas of metastasis with lower ADC
and another areas without metastasis with higher ADC, and
also the ROI of the ADC in a lymph node may be heteroge-
neous, containing metastatic and non-metastatic portions.
On the other hand, in non-metastatic LNs diffusion of water
molecules may be limited by inflammatory cell infiltration,
reactive hyperplasia, or fibrous connective tissue proliferation
which leads to decrease in ADC value.
We observed a wide variation in the mean and cutoff value
of ADC between the different studies, and in the present one,
we found that the mean ADC for metastatic and non
metastatic LNs was 0.86 ± 0.9  103 mm2/s and 1.53
± 0.6  103 mm2/s respectively and the cutoff value ofiables and its combination.
ivity (%) Specificity (%) PPV (%) NPV (%) Accuracy (%)
85.4 91 94.6 94.3
95.2 96.9 97.5 97.4
52.4 64.2 43.4 54.3
85 97.3 95 94.8
95 97 97.3 97.5
Table 3 Median, range, sensitivity, specificity, PPV, NPV and accuracy of ADC value at different N stages.
Variables N stage
N1 (mic) N1 N2
ADC value
Median 1.3  103 mm2/s 0.45  103 mm2/s 0.22  103 mm2/s
Range 0.74–1.26  103 mm2/s 0.64–1.26  103 mm2/s 0.13–0.98  103 mm2/s
Sensitivity 96.1% 97.3% 98%
Specificity 93.7% 94.2% 95%
PPV 95.9% 96% 96.3%
NPV 96.7% 97% 97.2%
Accuracy 96.2% 96.9% 97.1%
666 F. Zaiton et al.ADC for differentiating benign from malignant nodes was
1.09  103 mm2/s, with a sensitivity of 94.6%, a specificity
of 93.6%, PPV of 96%, NPV of 94.7% and accuracy of
95.6%, which is nearly the same as the results of Perrone
et al. (12), who found that the mean ADC value for malignant
lesions was 0.85  103 mm2/s, and 1.448  103 mm2/s for
benign ones while the cutoff value of ADC for differentiating
benign from malignant nodes was 1.03  103 mm2/s, with a
sensitivity of 100% and a specificity of 92.9%. Also, Isıl
et al. (42) used 1.22  103 mm2/s as the cutoff value of
ADC, with a sensitivity of 75.6% and a specificity of 71.1%.
And Ismail et al. (38) used the optimal 0.8  103 mm2/s as
ADC cutoff value for distinguishing benign and malignant
lymph nodes with recorded accuracy 96.7%, sensitivity
100%, specificity 87%, PPV 95.4% and NPV 100%. Also
Wang’s et al. (24) results in their study on rabbit models
showed that the ADC value of the axillary inflammatory
lymph nodes (0.9 ± 0.14) was significantly higher than that
of metastatic ones (0.7 ± 0.18). The researchers have been
attributed this variation to that ADC value which had been
affected by many factors, such as MRI acquisition parameters,
the magnetic field, location, size and area of ROI, patient age
as well as the body temperature (36).
In contrast to these results other publication described that
the ADC value of metastatic LNs was significantly higher than
that of non metastatic one (1,43,44); the difference between
those studies and our one had been explained by the differences
in the histological types; and also in the study of Kamitani
et al. (1) they did not use a node by node basis to compare
the DWI with histopathology results.
In this study we also examined the value of combination of
various predictors on the detectability of axillary LNs metasta-
sis, and we found that adding the high signal intensity of the
LNs on DWI to the cutoff value of the ADC improves the sen-
sitivity, specificity, PPV, NPV and accuracy of the test measur-
ing 98.4%, 95.2%, 96.9%, 97.5%, and 97.4%. Also we
observed increase in the examination sensitivity when using
all of high signal on DWI, ADC cutoff value as well as loss
of the fatty hilum in combination measuring 98.4%, 97.5%,
98.4%, 97.5%, and 98%, but the results were not better when
we used the size criteria in addition, and this is in accordance
with Kamitani et al. (1), who stated that the use of high signal
intensity on DWI and the threshold ADC value in combina-
tion has increased the diagnostic accuracy for differentiating
metastatic from benign lymph nodes. Also Kvistad et al. (45)
in their study on dynamic contrast enhanced MRI in the pre-
operative diagnosis of axillary LNs metastasis, concluded thattheir results were not better when the size and morphology of
the lymph node were used as additional criteria.
In the present study we try to avoid the limitations men-
tioned in previous publications, as we examined the lymph
nodes on node by node basis and not patient by patient basis;
we included the patients blindly prior to operation or LN
biopsy; and additionally we made a combined assessment of
the criteria examined. However, we faced several other limita-
tions. First: all included patients had breast cancer and this
may lead to bias. Second: the low spatial resolution is more
worse at high b values (b= 1000 s/mm2), which was necessary
to improve the sensitivity of DWI. The third limitation was as
described previously that MRI has low sensitivity in detecting
LNs less than 5 mm in diameter, reducing the detect-ability of
the LNs in our study. MRI could detect only 44.8% of the sur-
gically excised LNs.
In conclusion, no currently accurate MR criteria are estab-
lished for the determination of axillary nodal metastasis in
breast cancer patients. However, we found a high sensitivity
when using DWI and ADC in the detection of metastatic
LNs. Also, the combination of the cutoff value of ADC and
lost fatty hila has increased the diagnostic accuracy for distin-
guishing metastatic from benign lymph nodes.
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